Research Updates

Back to feed
PubMed
Research review

High importance

Oct 2, 2026

Comparative treatment outcomes of management modalities for unruptured brain arteriovenous malformations: a systematic review and meta-analysis of 6,124 patients.

View original source

Why it matters

Determining the optimal management strategy for unruptured brain AVMs is crucial, as it can directly impact patient outcomes and assist practitioners in crafting individualized treatment plans.

Objective

To evaluate the comparative effectiveness of different management strategies for unruptured brain arteriovenous malformations (AVMs) in order to guide clinical decision-making.

Results

Microsurgery demonstrated the highest obliteration rates (99% for Spetzler-Martin I-II; 86% for SM-III) and the lowest hemorrhage risk (annual rates of 0.6% for SM I-II; 1.3% for SM-III). Functional outcomes were superior with microsurgery (8% disability vs. 11% for conservative management). SRS had moderate obliteration rates (76% for SM I-II; 47% for SM III-IV) and a higher risk of latency-period hemorrhages (1.1-2.1%/yr), with similar disability rates to conservative management (13%). Mortality was low across treatment methods, ranging from 1-2%.

Methods

This systematic review and meta-analysis included 16 studies with 6,124 patients, comparing conservative management, microsurgery, stereotactic radiosurgery (SRS), embolization, and hybrid therapies. Primary outcomes measured were hemorrhage risk and obliteration rates, while secondary outcomes included functional status, new-onset seizures, and mortality.

Limitations

The studies included varied in methodologies, and there may be inherent biases in reporting outcomes. The analysis may not encompass all relevant patient subgroups or novel treatments.

For your doctor:

PMID: 42826096

DOI: 10.1080/01616412.2026.2741676

Abstract

BACKGROUND: The optimal management of unruptured brain arteriovenous malformations (AVMs) remains controversial, with conflicting evidence regarding conservative versus interventional approaches, particularly following the ARUBA trial. This meta-analysis aims to provide comprehensive, grade-individualized outcomes across treatment modalities to guide clinical decision-making. METHODS: We conducted a PRISMA-compliant meta-analysis of 16 studies (n = 6,124 patients) comparing conservative management, microsurgery, stereotactic radiosurgery (SRS), embolization, and hybrid therapy. Primary outcomes were hemorrhage risk and obliteration rates; secondary outcomes included functional status (mRS ≥2), new-onset seizures, and mortality. . RESULTS: Microsurgery achieved the highest obliteration rates (99% for Spetzler-Martin [SM] I-II, 86% for SM-III) and lowest hemorrhage risk (0.6%/yr for SM I-II, 1.3%/yr for SM-III), with superior functional outcomes (8% disability [95% CI 5-11%] vs. 11% for conservative management; p = 0.04). SRS showed moderate efficacy (76% obliteration for SM I-II, 47% for SM III-IV) with higher latency-period hemorrhage risk (1.1-2.1%/yr) and disability rates comparable to conservative management (13% [95% CI 10-16%]; p = 0.18). New-onset seizures occurred in 9.1% of microsurgery and 4.9% of SRS cases. Mortality was low across treatments (1-2%), with conservative management at 1.1% and SRS at 1.6%. Conservative management had a 1.9-2.6%/yr hemorrhage risk without procedural morbidity. . CONCLUSIONS: Among the available published evidence, microsurgery was associated with the most favourable pooled outcomes for operable SM I-II AVMs, including high obliteration rates, lower haemorrhage rates, and favourable functional outcomes, despite a higher seizure risk. SRS remains an important treatment option for inoperable lesions, while conservative management appears reasonable for high-grade AVMs in the absence of high-risk features.